-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OeBuLWSDkjLIqRr5cxhz3cvVpAlLpCUme4EE/5QLdLs0uD5YMcip0D7q+IEjn8h8 brEy6HQByP5KtA/RpJ1FmA== 0001025537-98-000010.txt : 19980227 0001025537-98-000010.hdr.sgml : 19980227 ACCESSION NUMBER: 0001025537-98-000010 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19980226 SROS: NASD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ORPHAN MEDICAL INC CENTRAL INDEX KEY: 0000929548 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411784594 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: SEC FILE NUMBER: 005-45345 FILM NUMBER: 98550752 BUSINESS ADDRESS: STREET 1: 13911 RIDGEDALE DR STE 475 CITY: MINNETONKA STATE: MN ZIP: 55305 BUSINESS PHONE: 6125411868 MAIL ADDRESS: STREET 1: 13911 RIGEDALE DR STREET 2: STE 475 CITY: MINNETONKA STATE: MN ZIP: 55305 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: LAMBERT PAUL T CENTRAL INDEX KEY: 0001056572 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: 0 STREET 2: PO BOX 11063 CITY: TELLURIDE STATE: CO ZIP: 81435 BUSINESS PHONE: 8707281777 SC 13D 1 SCHEDULE 13D FOR PAUL T. LAMBERT 2/13/96 Page 1 of 6 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. __)* ORPHAN MEDICAL INC. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock - -------------------------------------------------------------------------------- (Title of Class of Securities) 687303107 - -------------------------------------------------------------------------------- (CUSIP Number) Paul T. Lambert, P.O. Box 11063, 103 Elk Run Way, Telluride, CO 81435 (970) 728-1777 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) February 13, 1998 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(d)(e), 13(d)-1(g), check the following box |__|. NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other parties to whom copies are to be sent. *The remainder of this cover page will be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 2 of 6 SCHEDULE 13D - -------------------------- -------------------------- CUSIP NO. 687303107 PAGE 2 OF 6 PAGES - -------------------------- -------------------------- - -------------------------------------------------------------------------------- 1 Name of Reporting Person S.S. or I.R.S. Identification No. of Above Person Paul T. Lambert (###-##-####) - -------------------------------------------------------------------------------- 2 Check The Appropriate Box if a Member of a Group* (a) |__| (b) |__| - -------------------------------------------------------------------------------- 3 SEC Use Only - -------------------------------------------------------------------------------- 4 Source of Funds* PF - -------------------------------------------------------------------------------- 5 Check Box if Disclosure of Legal Proceedings is Required Pursuant to Item 2(d) or 2(e)* |__| - -------------------------------------------------------------------------------- 6 Citizenship or Place of Organization United States - -------------------------------------------------------------------------------- Number of 7 Sole Voting Power Shares 325,000 Beneficially ---------------------------------------------------------------- Owned By Each 8 Shared Voting Power Reporting None Person With ---------------------------------------------------------------- 9 Sole Dispositive Power 325,000 ---------------------------------------------------------------- 10 Shared Dispositive Power None - -------------------------------------------------------------------------------- 11 Aggregate Amount Beneficially Owned by Each Reporting Person 325,000 - -------------------------------------------------------------------------------- 12 Check Box if The Aggregate Amount in Row (11) Excludes Certain Shares* |__| - -------------------------------------------------------------------------------- 13 Percent of Class Represented by Amount in Row (11) 5.4% - -------------------------------------------------------------------------------- 14 Type of Reporting Person* IN - -------------------------------------------------------------------------------- *See Instructions Before Filling Out! Include Both Sides of the Cover Page, Responses to Items 1-7 - -------------------------------------------------------------------------------- Page 3 of 6 ITEM 1. SECURITY AND ISSUER The title of the class of equity securities to which this schedule relates is common stock, par value $.01, of Orphan Medical Inc. (the "Issuer"). The principal executive office and mailing address of the Issuer is 13911 Ridgedale Drive #475, Minnetonka, MN 55305. ITEM 2. IDENTITY AND BACKGROUND The person filing this Schedule is Paul T. Lambert. Mr. Lambert's business address is P.O. Box 11063, 103 Elk Run Way, Telluride, Colorado 81435 and his occupation is real estate investment. Mr. Lambert is a United States citizen. Mr. Lambert has not, during the last five years (excluding traffic violations or similar misdemeanors), been convicted in a criminal proceeding or been a party to a civil proceeding which involved a claimed violation of federal or state securities laws. ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION Mr. Lambert used personal funds to acquire the 325,000 shares of common stock of the Issuer (the "Shares"). ITEM 4. PURPOSE OF TRANSACTION Mr. Lambert acquired the Shares for personal investment. ITEM 5. INTEREST IN SECURITIES OF THE ISSUER (a) Mr. Lambert owns an aggregate of 325,000 Shares, representing 5.4% of the issued and outstanding stock of the Issuer. (b) Mr. Lambert has the sole power to vote or to direct the vote, and the sole power to dispose or to direct the disposition, of the Shares. (c) Mr. Lambert effected the following transactions in the Shares during the past sixty days: # DATE P TRANSACTION SECURITY QTY PRICE - ---- ------------- -------- --- ----- 1 1/08/98 P Bought ORPH 2000 5 1/8 2 2/03/98 P Sold ORPH 2000 6 3/8 3 2/12/98 P Bought ORPH 1000 7 1/4 Page 4 of 6 # DATE P TRANSACTION SECURITY QTY PRICE - ---- ------------- -------- --- ----- 4 2/12/98 P Bought ORPH 1000 7 1/4 5 2/13/98 P Bought ORPH 2000 7 1/4 6 2/13/98 P Bought ORPH 2000 7 1/4 7 2/13/98 P Bought ORPH 2000 7 1/4 8 2/13/98 P Bought ORPH 2000 7 1/4 9 2/13/98 P Bought ORPH 1450 7 3/8 10 2/17/98 P Bought ORPH 2500 7 5/8 11 2/17/98 P Bought ORPH 2000 7 5/8 12 2/17/98 P Bought ORPH 2500 7 5/8 13 2/17/98 P Bought ORPH 5000 7 All of the foregoing transactions were private transactions made by Mr. Lambert for Mr. Lambert's personal investment with his personal funds. (d) No person other than Mr. Lambert has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares. (e) Not applicable. Page 5 of 6 ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER There are no contracts, arrangements, understandings or relationships (legal or otherwise) among the persons named in Item 2 or between such persons and any person with respect to any securities of the Issuer. None of the Shares are pledged or otherwise subject to a contingency, the occurrence of which would give any person, other than Mr. Lambert voting power or investment power over the Shares. ITEM 7. MATERIAL TO BE FILED AS EXHIBITS No exhibits are filed as part of this Schedule 13D. Page 6 of 6 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Schedule 13D is true, complete and correct. Dated: February 26, 1998 By /s/ Paul T. Lambert --------------------------------- PAUL T. LAMBERT -----END PRIVACY-ENHANCED MESSAGE-----